
Oral controlled-release drug delivery technologies have the ability to improve the performance of a wide variety of existing pharmaceutical compounds. The therapeutic effect of a drug compound will typically vary according to its bloodstream concentration. When the concentration is too low, efficacy may be reduced and when it is too high, side effects may increase. |

Our product pipeline is well diversified from an indication as well as stage of development point of view. Presently, we have partnership agreements in place for five of our products and are in discussions with potential partners for the balance of our pipeline.
|